By detecting specific tumor methylation sites of circulating tumor DNA (ctDNA) in the blood, it is used to determine the likelihood of tumor lesions in the patient's lungs. Compared with traditional testing methods, the blood methylation testing technology has the characteristics of earlier, more accurate, safer and more convenient。